Camille Lécuroux

2.5k total citations
33 papers, 935 citations indexed

About

Camille Lécuroux is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Camille Lécuroux has authored 33 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Virology, 22 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Camille Lécuroux's work include HIV Research and Treatment (30 papers), Immune Cell Function and Interaction (21 papers) and HIV/AIDS Research and Interventions (9 papers). Camille Lécuroux is often cited by papers focused on HIV Research and Treatment (30 papers), Immune Cell Function and Interaction (21 papers) and HIV/AIDS Research and Interventions (9 papers). Camille Lécuroux collaborates with scholars based in France, United States and Italy. Camille Lécuroux's co-authors include Laurence Meyer, Alain Venet, Cécile Goujard, Olivier Lambotte, Isabelle Girault, Martine Sinet, Asier Sáez‐Cirión, Faroudy Boufassa, Christine Rouzioux and Véronique Avettand-Fènoël and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Camille Lécuroux

33 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille Lécuroux France 19 707 478 395 186 174 33 935
Olivier Lambotte France 10 575 0.8× 388 0.8× 295 0.7× 88 0.5× 121 0.7× 18 692
Claire Vandergeeten United States 10 762 1.1× 332 0.7× 515 1.3× 107 0.6× 168 1.0× 11 861
Christina Thobakgale South Africa 13 612 0.9× 401 0.8× 398 1.0× 54 0.3× 139 0.8× 26 810
Souheil-Antoine Younes United States 6 410 0.6× 391 0.8× 143 0.4× 97 0.5× 195 1.1× 6 621
Brian Tabb United States 8 597 0.8× 461 1.0× 250 0.6× 147 0.8× 206 1.2× 9 939
Judith Dalmau Spain 15 705 1.0× 385 0.8× 471 1.2× 75 0.4× 162 0.9× 29 940
Natalia Soriano-Sarabia United States 17 760 1.1× 555 1.2× 408 1.0× 93 0.5× 268 1.5× 42 1.1k
Montserrat Plana Spain 15 582 0.8× 230 0.5× 440 1.1× 95 0.5× 170 1.0× 24 748
Julie Lewis United Kingdom 6 737 1.0× 464 1.0× 375 0.9× 169 0.9× 222 1.3× 6 958
S. Schnittman United States 11 823 1.2× 391 0.8× 480 1.2× 105 0.6× 268 1.5× 13 991

Countries citing papers authored by Camille Lécuroux

Since Specialization
Citations

This map shows the geographic impact of Camille Lécuroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Lécuroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Lécuroux more than expected).

Fields of papers citing papers by Camille Lécuroux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Lécuroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Lécuroux. The network helps show where Camille Lécuroux may publish in the future.

Co-authorship network of co-authors of Camille Lécuroux

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Lécuroux. A scholar is included among the top collaborators of Camille Lécuroux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Lécuroux. Camille Lécuroux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braudeau, Cécile, Laurence Bouchet‐Delbos, Camille Lécuroux, et al.. (2023). System-level immune monitoring reveals new pathophysiological features in hepatitis-associated aplastic anemia. Blood Advances. 7(15). 4039–4045. 1 indexed citations
2.
Lécuroux, Camille, Véronique Avettand-Fènoël, Faroudy Boufassa, et al.. (2021). CXCR3 and CXCR5 are highly expressed in HIV‐1‐specific CD8 central memory T cells from infected patients. European Journal of Immunology. 51(8). 2040–2050. 3 indexed citations
3.
Plaçais, Léo, Faroudy Boufassa, Camille Lécuroux, et al.. (2021). Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort. EClinicalMedicine. 37. 100963–100963. 5 indexed citations
4.
Lécuroux, Camille, Cécile Goujard, Jacques Reynes, et al.. (2020). Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection. EBioMedicine. 62. 103129–103129. 28 indexed citations
5.
Avettand-Fènoël, Véronique, Faroudy Boufassa, Camille Lécuroux, et al.. (2019). Dynamics in HIV‐DNA levels over time in HIV controllers. Journal of the International AIDS Society. 22(1). e25221–e25221. 13 indexed citations
6.
Tchitchek, Nicolas, Bruno Vaslin, Christine Bourgeois, et al.. (2019). Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection. Frontiers in Immunology. 10. 2677–2677. 18 indexed citations
7.
Lécuroux, Camille, Véronique Avettand-Fènoël, Antoine Chéret, et al.. (2019). The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients. AIDS. 33(14). 2137–2147. 2 indexed citations
8.
Tchitchek, Nicolas, Bruno Vaslin, Christine Bourgeois, et al.. (2018). Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a+ CD4+ T Cells From Early HIV Infection to Effective cART. Frontiers in Immunology. 9. 1217–1217. 10 indexed citations
9.
Gondois‐Rey, Françoise, Antoine Chéret, Samuel Granjeaud, et al.. (2017). NKG2C+ memory‐like NK cells contribute to the control of HIV viremia during primary infection: Optiprim‐ANRS 147. Clinical & Translational Immunology. 6(7). e150–e150. 45 indexed citations
10.
Canouï, Étienne, Camille Lécuroux, Véronique Avettand-Fènoël, et al.. (2017). A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level. Open Forum Infectious Diseases. 4(2). ofx064–ofx064. 30 indexed citations
11.
Gondois‐Rey, Françoise, Antoine Chéret, Françoise Mallet, et al.. (2017). A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART. Frontiers in Immunology. 8. 54–54. 23 indexed citations
12.
Krastinova, Evguenia, Camille Lécuroux, Carole Leroy, et al.. (2015). High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression. The Journal of Infectious Diseases. 212(6). 909–913. 27 indexed citations
13.
Noël, Nicolas, Nathalie Lerolle, Camille Lécuroux, et al.. (2015). Immunologic and Virologic Progression in HIV Controllers: The Role of Viral “Blips” and Immune Activation in the ANRS CO21 CODEX Study. PLoS ONE. 10(7). e0131922–e0131922. 38 indexed citations
14.
Hua, Stéphane, Camille Lécuroux, Asier Sáez‐Cirión, et al.. (2014). Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers. PLoS ONE. 9(7). e101920–e101920. 49 indexed citations
15.
Lécuroux, Camille, Isabelle Girault, Antoine Chéret, et al.. (2013). CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection. PLoS ONE. 8(3). e59767–e59767. 15 indexed citations
16.
Noël, Nicolas, Faroudy Boufassa, Camille Lécuroux, et al.. (2013). Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS. 28(4). 467–476. 74 indexed citations
17.
Simonetta, Federico, Camille Lécuroux, Isabelle Girault, et al.. (2012). Early and Long-Lasting Alteration of Effector CD45RA−Foxp3high Regulatory T-Cell Homeostasis During HIV Infection. The Journal of Infectious Diseases. 205(10). 1510–1519. 48 indexed citations
18.
Lécuroux, Camille, Asier Sáez‐Cirión, Nicolas Noël, et al.. (2012). NKG2D Expression on HIV-Specific CD8+ T cells Is Reduced in Viremic HIV-1–Infected Patients but Maintained in HIV Controllers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(1). 17–20. 4 indexed citations
19.
Liovat, Anne-Sophie, Marie-Anne Rey-Cuillé, Camille Lécuroux, et al.. (2012). Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection. PLoS ONE. 7(10). e46143–e46143. 120 indexed citations
20.
Lécuroux, Camille, Isabelle Girault, Alejandra Urrutia, et al.. (2009). Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells. AIDS. 23(13). 1649–1658. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026